Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2468 of 3330
Next
>>
>
61676 to 61700 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Antibody	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF12A	NM	Basal B		Pertuzumab			0.25	mg/ml	7489.102	0.8804	0.8976	2.4234
MCF12A	NM	Basal B		Pertuzumab			1.25	mg/ml	7489.102	0.8528	0.8728	2.4234
184A1	NM	Basal	PS-1145		IKK	NFKB	0.00485	uM	5894.065	1.0451	1.0557	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	0.0243	uM	5894.065	1.0293	1.0363	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	0.121	uM	5894.065	1.0092	1.0115	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	0.606	uM	5894.065	1.0442	1.0545	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	3.03	uM	5894.065	1.0480	1.0593	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	15.2	uM	5894.065	1.0062	1.0077	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	75.8	uM	5894.065	1.0259	1.0321	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	379	uM	5894.065	0.9506	0.9379	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	1890	uM	5894.065	0.8734	0.8384	1.6064
184A1	NM	Basal	PS-1145		IKK	NFKB	0.00485	uM	5895.065	1.0767	1.1105	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	0.0243	uM	5895.065	1.1328	1.1899	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	0.121	uM	5895.065	1.0964	1.1385	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	0.606	uM	5895.065	1.0610	1.0880	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	3.03	uM	5895.065	1.0597	1.0861	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	15.2	uM	5895.065	1.1299	1.1858	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	75.8	uM	5895.065	1.0184	1.0267	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	379	uM	5895.065	1.0021	1.0031	1.3748
184A1	NM	Basal	PS-1145		IKK	NFKB	1890	uM	5895.065	1.0092	1.0133	1.3748
184B5	NM	Basal	PS-1145		IKK	NFKB	0.00485	uM	5896.065	0.9942	0.9922	1.4978
184B5	NM	Basal	PS-1145		IKK	NFKB	0.0243	uM	5896.065	0.9839	0.9785	1.4978
184B5	NM	Basal	PS-1145		IKK	NFKB	0.121	uM	5896.065	0.9785	0.9711	1.4978
184B5	NM	Basal	PS-1145		IKK	NFKB	0.606	uM	5896.065	0.9685	0.9577	1.4978
184B5	NM	Basal	PS-1145		IKK	NFKB	3.03	uM	5896.065	0.9904	0.9872	1.4978

|<
<<
Previous
Page 2468 of 3330
Next
>>
>
61676 to 61700 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)